University of Zagreb’s Centre for Research, Development and Technology Transfer held a Morning Health Talks series. The aim of the event was to connect important stakeholders in the field of health in order to encourage the development of the local ecosystem, and its theme was successful partnerships in the development of health innovations.
Participants of the event had the opportunity to hear the experiences of Prof. Dr Maja Čikeš from the Faculty of medicine at the University of Zagreb, who presented the ENVAD-HF project, a clinical study of the use of sacubitril/valsartan in a specific subpopulation of patients with heart failure, carriers OF heart pump – HM3 LVAD device (Heartmate3 left ventricular assist device). The project is sponsored by the University of Zagreb Medical Faculty and is financially supported by industry partners Novartis and Abbott.
After a lecture by Professor Čikeš, Dr Martin de Kort, Senior Scientific Programme Manager at EATRIS presented the RECOGNISED project (retinal and cognitive dysfunction in type 2 diabetes: unravelling the common pathways and identification of patients at risk of Dementia) and the formation of a consortium of 21 partners out of which 9 countries were presented by EATRIS. The RECOGNISED project investigates whether the changes in the retina caused by type 2 diabetes reflect changes in the brain resulting in cognitive disorder, or whether changes in the retina can be used for early detection of cognitive disorder in people with type 2 diabetes mellitus. The project has been implemented for a year, and in addition to clinical centres, the project includes patient associations, development (start-ups) and consulting firms. The project is coordinated by the Vall d’ Hebron Research Institute in Spain and the Queen’s University of Belfast in the UK. The role of the EATRIS network in the project is primarily innovation management, and their goal is to develop a product through the project based on research and create a business plan that will lead to the creation of a new spin-off subsidiary. Consulting firm Genesis is responsible for creating the business plan. The project is currently in the phase of clinical research.
This was referred from the Universitas Portal.